People and Business News — 1/22-2/22
People News
Cognivia announced Christian Jourquin became a member of its Board of Directors. While Graham Bunn, PhD, joined the team as Strategic Advisor to the Board.
Rho has promoted Mark Ubert, to the position of Chief Financial Officer.
mdgroup announced the appointment of Dr. Arthur Lazarus, as Medical Director. The company also has appointed Steph Katz as Director of business subsidiary Seacole Health.
Firma Clinical Research promoted Jennifer Mintz to Chief Commercial Officer.
Javara has appointed Tim Neathery as its first Chief Human Resources Officer.
QPS Holdings LLC announced that Dr. Manuela Prokesch has been selected as the new Director of Neuropharmacology.
Ora, Inc. announced that Dr. Gustavo De Moraes, has accepted the role of Chief Medical Officer.
Business News
NNIT became one of the first partners to be certified as a Premiere Services Partner for Veeva Development Cloud
Catalent announced that it has been officially recognized by the Top Employers Institute as a Top Employer 2022 in both the United States and the United Kingdom.
Novotech has been recognized as a top 10 CRO in the 2021 CenterWatch Global Site Relationship Benchmark Survey.
Calyx announced that a Top 20 specialty pharmaceutical company will continue to rely on their electronic data capture system for a series of upcoming, early phase studies.
Recognition
Clario has been named a Top Workplace by Energage.
Rho announced that its Chief Operating Officer, Tara Gladwell, has received a 2022 Women in Business Award from the Triangle Business Journal.
mdgroup has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 index.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
